PRKCE expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.11022302462516E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.54871728961371E-15 |
Normal-vs-Stage2 |
1.07019948458742E-10 |
Normal-vs-Stage3 |
1.11022302462516E-16 |
Normal-vs-Stage4 |
1.62447832963153E-12 |
Stage1-vs-Stage2 |
2.429800E-01 |
Stage1-vs-Stage3 |
1.916860E-03 |
Stage1-vs-Stage4 |
1.74529999996675E-06 |
Stage2-vs-Stage3 |
3.146800E-01 |
Stage2-vs-Stage4 |
2.382100E-02 |
Stage3-vs-Stage4 |
7.493700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62470037423645E-12 |
Normal-vs-AfricanAmerican |
1.62447832963153E-12 |
Normal-vs-Asian |
1.99354999999013E-05 |
Caucasian-vs-AfricanAmerican |
7.958100E-03 |
Caucasian-vs-Asian |
3.950600E-01 |
AfricanAmerican-vs-Asian |
9.313200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
3.04509750748139E-11 |
Male-vs-Female |
6.32899999999381E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
8.58489945798624E-11 |
Normal-vs-Age(41-60Yrs) |
1.6242562850266E-12 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
5.46449996363663E-09 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.363800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.157200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.980200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.809600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.075800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.912200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
2.982600E-03 |
Normal-vs-Grade 2 |
2.03737027248962E-12 |
Normal-vs-Grade 3 |
1.6242562850266E-12 |
Normal-vs-Grade 4 |
<1E-12 |
Grade 1-vs-Grade 2 |
4.545600E-01 |
Grade 1-vs-Grade 3 |
4.919700E-02 |
Grade 1-vs-Grade 4 |
1.74531000000089E-05 |
Grade 2-vs-Grade 3 |
3.057900E-03 |
Grade 2-vs-Grade 4 |
6.94689861191478E-11 |
Grade 3-vs-Grade 4 |
5.79210000000163E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.85890000562006E-09 |
Normal-vs-ccB subtype |
1.62447832963153E-12 |
ccA subtype-vs-ccB subtype |
1.05550002071908E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.6251444634463E-12 |
Normal-vs-N1 |
1.91889999445749E-08 |
N0-vs-N1 |
1.503820E-01 |
|
|